Algert Global’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Sell |
154,113
-184,500
| -54% | -$3.19M | 0.06% | 543 |
|
|
2025
Q1 | $7.41M | Buy |
338,613
+56,328
| +20% | +$1.23M | 0.18% | 155 |
|
|
2024
Q4 | $9.01M | Buy |
282,285
+199,874
| +243% | +$6.38M | 0.21% | 136 |
|
|
2024
Q3 | $2.38M | Sell |
82,411
-41,217
| -33% | -$1.19M | 0.06% | 499 |
|
|
2024
Q2 | $4.74M | Buy |
123,628
+71,650
| +138% | +$2.75M | 0.16% | 187 |
|
|
2024
Q1 | $3.06M | Buy |
51,978
+11,049
| +27% | +$649K | 0.12% | 290 |
|
|
2023
Q4 | $2.45M | Sell |
40,929
-19,375
| -32% | -$1.16M | 0.1% | 352 |
|
|
2023
Q3 | $2.29M | Buy |
60,304
+32,505
| +117% | +$1.24M | 0.11% | 320 |
|
|
2023
Q2 | $2.53M | Sell |
27,799
-14,900
| -35% | -$1.36M | 0.11% | 315 |
|
|
2023
Q1 | $2.82M | Buy |
42,699
+9,468
| +28% | +$624K | 0.13% | 234 |
|
|
2022
Q4 | $1.72M | Hold |
33,231
| – | – | 0.1% | 347 |
|
|
2022
Q3 | $2.27M | Buy |
33,231
+1,847
| +6% | +$126K | 0.14% | 234 |
|
|
2022
Q2 | $1.42M | Buy |
31,384
+11,121
| +55% | +$503K | 0.11% | 329 |
|
|
2022
Q1 | $1.03M | Buy |
20,263
+12,896
| +175% | +$656K | 0.07% | 513 |
|
|
2021
Q4 | $348K | Buy |
+7,367
| New | +$348K | 0.04% | 677 |
|
|
2021
Q2 | – | Sell |
-8,979
| Closed | -$385K | – | 425 |
|
|
2021
Q1 | $385K | Sell |
8,979
-23,424
| -72% | -$1M | 0.12% | 257 |
|
|
2020
Q4 | $1.85M | Sell |
32,403
-3,172
| -9% | -$181K | 0.53% | 50 |
|
|
2020
Q3 | $1.07M | Sell |
35,575
-12,560
| -26% | -$379K | 0.34% | 111 |
|
|
2020
Q2 | $1.57M | Sell |
48,135
-1,750
| -4% | -$57.2K | 0.53% | 49 |
|
|
2020
Q1 | $1.34M | Buy |
+49,885
| New | +$1.34M | 0.56% | 37 |
|